Joseph Edelman Overview
- Firm
- Perceptive Advis...
- Primary Position
-
Founder, Chief...
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Joseph Edelman General Information
Biography
Mr. Joseph Edelman is the Founder and serves as Co-Chairman of the Board of Trustees of The Edelman Family Foundation. He also is the Founder and serves as Chief Executive Officer, Board Member, and Portfolio Manager at Perceptive Advisors. He served as a Board Member at Xontogeny and Athira Pharma. He founded Perceptive Advisors in 1999. Previously, he was a Senior Analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund, from November 1994 through December 1998. Prior, he was a Senior Biotechnology Analyst at Prudential Securities for four years. He started his career in the healthcare sector of the securities industry as a Biotechnology Analyst at Labe, Simpson. He earned an M.B.A. from New York University and a B.A., magna cum laude, in psychology from the University of California San Diego. He served as Chairman at ARYA Sciences Acquisition Corp III.
Contact Information
Address
- 51 Astor Place
- 10th floor
- New York, NY 10003
- United States
Joseph Edelman Positions (2)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Perceptive Advisors | Investor | Founder, Chief Executive Officer, Board Member and Portfolio Manager | New York, NY | Hedge Fund | |
| The Edelman Family Foundation | Limited Partner | Founder & Co-Chairman of the Board of Trustees | New York, NY | Foundation |
Joseph Edelman Board Seats (3)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Athira Pharma | Drug Discovery | Publicly Held | Formerly VC-backed | Bothell, WA | |
| Perceptive Capital Solutions | Special Purpose Acquisition Company (SPAC) | Publicly Held | Corporation | New York, NY | |
| The Edelman Family Foundation | New York, NY |
Joseph Edelman Lead Partner on Deals (7)
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| ARYA Sciences Acquisition IV | 26-Feb-2021 | PIPE | Completed | Special Purpose Acquisition Company (SPAC) | New York, NY | |
| Athira Pharma | 04-Jun-2020 | Completed | Drug Discovery | Bothell, WA | ||
| Crinetics Pharmaceuticals | 17-Jul-2018 | Completed | Drug Discovery | San Diego, CA | ||
| Landos Biopharma | 19-Sep-2017 | Completed | Pharmaceuticals | Blacksburg, VA | ||
| Xontogeny | 18-May-2017 | Completed | Consulting Services (B2B) | Boston, MA | ||
| Outlook Therapeutics | 29-Sep-2015 | Later Stage VC | Completed | Drug Discovery | Iselin, NJ | |
| Bellicum Pharmaceuticals | 02-Sep-2014 | Later Stage VC (Series C) | Completed | Drug Discovery | Houston, TX |
Joseph Edelman Network (120)
Board Members (26)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Sanjiv Patel MD | ARYA Sciences Acquisition V | Self | New York, NY | |
| Mark McKenna | Perceptive Capital Solutions | Self | New York, NY | |
| ARYA Sciences Acquisition II | Self | New York, NY | ||
| Athira Pharma | Self | Bothell, WA | ||
| Athira Pharma | Self | Bothell, WA |
Portfolio Executives (78)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Rachel Lenington | Athira Pharma | Chief Operating Officer, Operations & Executive | 04-Jun-2020 | Bothell, WA |
| Glenna Mileson | Athira Pharma | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | 04-Jun-2020 | Bothell, WA |
| Athira Pharma | Medical, Strategic and Scientific Advisor | 04-Jun-2020 | Bothell, WA | |
| Athira Pharma | Advisor, Business and Strategy | 04-Jun-2020 | Bothell, WA | |
| Athira Pharma | Advisor, Business and Strategy | 04-Jun-2020 | Bothell, WA |
Fund Team Members (16)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Hossein Ekrami Ph.D | Perceptive Advisors | Perceptive Life Sciences Master Fund | New York, NY |
| Christopher Garabedian | Perceptive Advisors | Perceptive Xontogeny Venture Fund | New York, NY |
| Xontogeny | Boston, MA | ||
| Perceptive Advisors | New York, NY | ||
| Perceptive Advisors | New York, NY |
Joseph Edelman Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Perceptive Xontogeny Venture Fund | Perceptive Advisors | Venture Capital - Early Stage | Closed | 2020 | ||||
| Perceptive Credit Opportunities Fund | Perceptive Advisors | Credit Special Situations | Closed | 2016 | ||||
| Perceptive Life Sciences Master Fund | Perceptive Advisors | Hedge Fund | Open |
Joseph Edelman FAQs
-
Who is Joseph Edelman?
Mr. Joseph Edelman is the Founder and serves as Co-Chairman of the Board of Trustees of The Edelman Family Foundation.
-
How much does Joseph Edelman typically invest?
Joseph Edelman's median deal size is .
-
What is Joseph Edelman’s main position?
Joseph Edelman’s primary position is Founder, Chief Executive Officer, Board Member and Portfolio Manager.
-
What are the contact details for Joseph Edelman?
Joseph Edelman’s email address is jo and his phone number is +1 (646) .
-
How many active board seats does Joseph Edelman hold?
Joseph Edelman holds 3 board seats including Athira Pharma, Perceptive Capital Solutions, and The Edelman Family Foundation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
